Newsroom

May 2017

• 
  Story May 25, 2017 Patient Perspectives

  Choosing the right care

  Melanoma survivor T.J. Sharpe shares why patients should know their treatment options.

• Press release May 23, 2017

  Novartis' new analyses reinforce the potential of Ultibro® Breezhaler® for COPD patients historically treated with steroids

  New analyses from the FLAME study suggest dual bronchodilator Ultibro® Breezhaler® provides similar or better efficacy versus steroid-containing therapies, regardless of blood eosinophil (a type of…
• Press release May 19, 2017

  Novartis receives positive CHMP opinion for first-line use of Zykadia® in ALK-positive advanced non-small cell lung cancer (NSCLC)

  Phase III trial, first-line treatment with Zykadia resulted in improved progression-free survival (PFS) over SOC chemotherapy with maintenance, including in patients with brain metastases[1]…
• Press release May 18, 2017

  Novartis data at ASCO, ICML and EHA meetings demonstrate meaningful advancements in cancer care

  Updated analyses from the Kisqali® pivotal Phase III MONALEESA-2 trial in hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced breast cancer to be…
• Press release May 17, 2017

  Novartis Foundation and partners launch initiative to tackle hypertension and its root causes in low-income urban communities

  Better Hearts Better Cities is a Novartis Foundation initiative to improve cardiovascular health in low-income urban communities by addressing the prevention, management and control of hypertension…
• 
  Story May 15, 2017 Discovery

  Women in Science: Renee Rodgers

• 
  Story May 15, 2017 Access to Healthcare

  Novartis invites scrutiny of effort to improve access to medicine

  Public health expert Richard Laing discusses how independent measurement of access programs can help ensure their success

• In The News May 12, 2017

  Novartis Access and government of Pakistan sign memorandum of understanding

  Novartis reaches agreement with Pakistan to increase access to medicines that address the rapid rise of chronic illness among poor people in the world's sixth most populous nation.
• Press release May 11, 2017

  Novartis celebrates 21st annual Community Partnership Day with over 24,500 associates volunteering in their local communities

  Community Partnership Day symbolizes the company's commitment to improving people's lives and serving our local communities  Follow the excitement with #NovartisCPD2017 and #proudmoments2017 via…
• In The News May 10, 2017

  Novartis Access perspective: The key to fighting chronic disease in South-East Asia - young people

  Harald Nusser, Head of Novartis Social Business, explains why educating young people is key to fighting chronic disease in South-East Asia.
• 
  Story May 05, 2017 Discovery

  Taking clinical trials to the next level through technology

  Learn how Novartis is using technology to improve the oncology clinical trial process.

• Press release May 04, 2017

  Novartis exercises exclusive option agreement with Conatus for the treatment of NASH

  Exclusive license for emricasan supports rapidly growing development portfolio in chronic liver diseases, including NASH  Conatus has initiated the Phase IIb ENCORE-LF clinical trial with…